Back to Search
DENISE GARVEY, MD
MD
Internal Medicine Physician
NPI: 1265457436IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
A55477(CA)
Education
UNIVERSITY OF CALIFORNIA, GEFFEN SCHOOL OF MEDICINE
Class of 1994
Research & Publications (18)
Improved resolution haplogroup G phylogeny in the Y chromosome, revealed by a set of newly characterized SNPs.
PMID 19495413·PLoS One·2009
7-preclinical
Structure-based design, synthesis, and biological evaluation of indomethacin derivatives as cyclooxygenase-2 inhibiting nitric oxide donors.
PMID 17994684·J Med Chem·2007
7-preclinical
Verification of helical tomotherapy delivery using autoassociative kernel regression.
PMID 17879788·Med Phys·2007
8-other
Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers.
PMID 17305573·Curr Top Med Chem·2007
6-review
Sub-populations within the major European and African derived haplogroups R1b3 and E3a are differentiated by previously phylogenetically undefined Y-SNPs.
PMID 17154278·Hum Mutat·2007
8-other
Synthesis and anti-inflammatory activity of a series of N-substituted naproxen glycolamides: nitric oxide-donor naproxen prodrugs.
PMID 16356728·Bioorg Med Chem·2006
7-preclinical
NMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donor.
PMID 16259719·Inflammopharmacology·2005
7-preclinical
A comparison of the cyclooxygenase inhibitor-NO donors (CINOD), NMI-1182 and AZD3582, using in vitro biochemical and pharmacological methods.
PMID 16168964·Biochem Pharmacol·2005
4-observational
3-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) phenyl ketone as a potent and orally active cyclooxygenase-2 selective inhibitor: synthesis and biological evaluation.
PMID 15916445·J Med Chem·2005
7-preclinical
3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
PMID 15546727·Bioorg Med Chem Lett·2004
8-other
Combination of paclitaxel and nitric oxide as a novel treatment for the reduction of restenosis.
PMID 15084126·J Med Chem·2004
7-preclinical
Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
PMID 15084117·J Med Chem·2004
7-preclinical
Synthesis and selective cyclooxygenase-2 (COX-2) inhibitory activity of a series of novel bicyclic pyrazoles.
PMID 15018908·Bioorg Med Chem·2004
8-other
Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitors.
PMID 14640557·J Med Chem·2003
7-preclinical
Implementation of a primary care physician network obesity management program.
PMID 11707560·Obes Res·2001
8-other
First examples of oxidizing secondary alcohols to ketones in the presence of the disulfide functional group: synthesis of novel diketone disulfides.
PMID 11375028·J Org Chem·2001
8-other
Nitrosothiol esters of diclofenac: synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs.
PMID 11052806·J Med Chem·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11980 SAN VICENTE BLVD, 102
LOS ANGELES, CA 90049 - Phone
- (301) 208-7777
Quick Facts
- NPI
- 1265457436
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 18
Are you this provider?
Claim Your Profile